 |
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
*Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; and Departments of Medicine and Pathology, University of North Carolina, Chapel Hill, North Carolina
Correspondence to Dr. Jeffrey Kopp, 10/3N116, NIH, Bethesda, MD 20892-1268. Phone: 301-594-3403; Fax: 301-402-0014; E-mail: jbkopp{at}nih.gov
ABSTRACT. Simian virus 40 (SV40), a monkey polyomavirus that is believed to have entered the human population through contaminated vaccines, is known to be renotropic in simians. If indeed SV40 is endemic within the human population, the route of transmission is unknown. It was therefore hypothesized that SV40 might be renotropic in humans and be detected more frequently in samples obtained from patients with kidney diseases. This study found that typical polyomavirus cytopathic effects (CPE) were present and SV40 T antigen was detected in CV-1 cells cultured with peripheral blood mononuclear cells (PBMC) or urinary cells obtained from patients with kidney disease and healthy volunteers. DNA sequences homologous to the SV40 viral regulatory genome were detected by PCR in urinary cells from 15 (41%) of 36 patients with focal segmental glomerulosclerosis (FSGS), 2 (10%) of 20 patients with other kidney diseases, and 1 (4%) of 22 healthy volunteers (FSGS compared with other glomerular disease, P < 0.02; FSGS compared with healthy volunteers, P = 0.003). SV40 viral regulatory region genome was detected from PBMC at similar frequencies in patients with FSGS (35%), other glomerular diseases (20%), and healthy volunteers (22%). SV40 genome was detected by PCR in kidney tissues from 17 (56%) of 30 of patients with FSGS and 4 (20%) of 20 patients with minimal change disease and membranous nephropathy (P < 0.01). Considerable genetic heterogeneity of the viral regulatory region was detected, which argues against laboratory contamination. SV40 genome was localized to renal tubular epithelial cell nuclei in renal biopsies of patients with FSGS by in situ hybridization. This study demonstrates for the first time that human kidney can serve as a reservoir for SV40 replication and that SV40 may contribute to the pathogenesis of kidney disease, particularly FSGS.
This article has been cited by other articles:
 |
|
 |
|
  V. Sroller, R. A. Vilchez, A. R. Stewart, C. Wong, and J. S. Butel Influence of the Viral Regulatory Region on Tumor Induction by Simian Virus 40 in Hamsters J. Virol., January 15, 2008; 82(2): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Bohl and D. C. Brennan BK Virus Nephropathy and Kidney Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S36 - S46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swaminathan, D. J. Lager, X. Qian, M. D. Stegall, T. S. Larson, and M. D. Griffin Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2607 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L P. Marques, G G. Pacheco, L S Rioja, S N Nunes, S T Velone, and O R Santos Can systemic lupus erythematosus be the cause of collapsing glomerulopathy? Lupus, October 1, 2005; 14(10): 853 - 855. [Abstract] [PDF]
|
|
|
|
 |
|
 J. J. Manfredi, J. Dong, W.-j. Liu, L. Resnick-Silverman, R. Qiao, P. Chahinian, M. Saric, A. R. Gibbs, J. I. Phillips, J. Murray, et al. Evidence against a Role for SV40 in Human Mesothelioma Cancer Res., April 1, 2005; 65(7): 2602 - 2609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Meyrier Nephrotic focal segmental glomerulosclerosis in 2004: an update Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2437 - 2444. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Vilchez and J. S. Butel Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer Clin. Microbiol. Rev., July 1, 2004; 17(3): 495 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shaikh, C. Skoczylas, R. Longnecker, and K. Rundell Inability of Simian Virus 40 To Establish Productive Infection of Lymphoblastic Cell Lines J. Virol., May 1, 2004; 78(9): 4917 - 4920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kunin, J. Kopolovic, A. Avigdor, and E. J. Holtzman Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient Nephrol. Dial. Transplant., March 1, 2004; 19(3): 723 - 726. [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Kimmel, L. Barisoni, and J. B. Kopp Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations Ann Intern Med, August 5, 2003; 139(3): 214 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Garcea and M. J. Imperiale Simian Virus 40 Infection of Humans J. Virol., May 1, 2003; 77(9): 5039 - 5045. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Engels, H. A. Katki, N. M. Nielsen, J. F. Winther, H. Hjalgrim, F. Gjerris, P. S. Rosenberg, and M. Frisch Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated With Simian Virus 40 J Natl Cancer Inst, April 2, 2003; 95(7): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
